Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 8/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.50 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.39 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.39 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.39 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.38 |
| ▸ | RRM1 | P23921 | 1/20 | 0.38 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.36 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.36 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL625808 | 0.88 | DNM1 (0.65) | DNM1MEN1KMT2AALDH1A1TSHR | |
| Isoamylamine SCHEMBL9319600 | 0.83 | DNM1 (0.63) | DNM1MEN1KMT2AALDH1A1TSHR | |
| Octane SCHEMBL9464723 | 0.79 | DNM1 (0.65) | DNM1MEN1KMT2AALDH1A1TSHR | |
| Dodecylamine SCHEMBL11781677 | 0.77 | DNM1 (0.67) | DNM1MEN1KMT2AALDH1A1TSHR | |
| Isoamylamine SCHEMBL28954758 | 0.76 | DNM1 (0.50) | DNM1MEN1KMT2AALDH1A1TSHR | |
| SCHEMBL11698236 | 0.75 | OPRM1 (0.41) | DNM1TSHRSPHK1OPRM1 | |
| SCHEMBL23631179 | 0.74 | DNM1 (0.72) | DNM1MEN1KMT2AALDH1A1TSHR | |
| Hexadecylamine SCHEMBL8855049 | 0.73 | DNM1 (0.81) | DNM1MEN1KMT2AALDH1A1TSHR | |
| SCHEMBL27921131 | 0.73 | — | — | |
| SCHEMBL27637578 | 0.73 | DNM1 (0.93) | DNM1MEN1KMT2AALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3294318-A1 | PEPTIDOMIMETIC MACROCYCLES AND USES THEREOF | Aileron Therapeutics, Inc. (US) | 2018-03-21 | — | — | EP | disclosed |
| EP-3197477-A1 | PEPTIDOMIMETIC MACROCYCLES AND FORMULATIONS THEREOF | Aileron Therapeutics, Inc. (US) | 2017-08-02 | — | — | EP | disclosed |
| WO-2016154058-A1 | PEPTIDOMIMETIC MACROCYCLES AND USES THEREOF | AILERON THERAPEUTICS, INC. (US) | 2016-09-29 | — | — | WO | disclosed |
| WO-2016049355-A1 | PEPTIDOMIMETIC MACROCYCLES AND FORMULATIONS THEREOF | AILERON THERAPEUTICS, INC. (US) | 2016-03-31 | — | — | WO | disclosed |
| EP-2819688-A1 | TRIAZOLE-CROSSLINKED AND THIOETHER-CROSSLINKED PEPTIDOMIMETIC MACROCYCLES | Aileron Therapeutics, Inc. (US) | 2015-01-07 | — | — | EP | disclosed |
| WO-2013123267-A1 | TRIAZOLE-CROSSLINKED AND THIOETHER-CROSSLINKED PEPTIDOMIMETIC MACROCYCLES | AILERON THERAPEUTICS, INC. (US) | 2013-08-22 | — | — | WO | disclosed |
| WO-2012021874-A1 | PEPTIDOMIMETIC MACROCYCLES WITH THIOETHER LINKERS | AILERON THERAPEUTICS, INC. (US) | 2012-02-16 | — | — | WO | disclosed |